Member Info for kezzman

looking good!

PDSB rise almost wiped out

but NSCI only own 7% of that increase

PDSB only up 5% NSCI own 7% of shares and are up nearly 150%?

strange world of shares will watch PDSB on the NASDAQ see price at close

The news was released at market open on the NASDAQ

Only 4.7% up on the news?

NSCI only have 7% of PDSB?

strange

.

.

is that not cross ramping?

what will happen to price when all those 45 shares hit the market

are peeps paying nearly double the placing price?

I know what I'd be doing once I get my 45 placing shares nearly 100% up

forward selling and shorting ahead

MESH can
independently emerge as a multi-brand self-sustainable market leading AI, machine learning
and contextualisation business.
MESH will provide its shareholders with a further update at the time of the proposed closing
of the ASLR transaction on or around 10 August 2020.
For further information:
MESH Holdings plc
Mike Power and Robert Bonnier via Buchanan
Buchanan Communications Limited
Richard Oldworth / Chris Lane Tel: +44 (0) 20 7466 5000

MESH Holdings PLC
(“MESH” or “the Company”)
Offer to acquire 100% of Sentiance NV (“Sentiance”)
MESH is pleased to confirm that it has recently made an Offer to acquire 100% of Sentiance.
At present, the Company owns around 14% of Sentiance equity and since January 2020 Mike
Power represents MESH on the Sentiance Board of Directors.
As part of the Offer for Sentiance, the Company has also made a specific proposal to Asimilar
Plc (“ASLR”). ASLR would receive a material compensation, paid for in restricted ordinary
MESH shares, in return for ASLR novating both its minority part of the extended Sentiance
Acquisition Option and the €15 million primary Sentiance equity subscription to MESH, as
was announced on 4 March 2020. ASLR and MESH have agreed that subject to formal
agreement and final documentation, they will aim to complete their part of the Offer
transaction by 10 August 2020.
Sentiance background
The Sentiance Motion Intelligence and Behavioural Change Platform enables leading direct
to-consumer companies to get a deep understanding of the individual user journey and adapt
their service offerings and engagement processes on a one-on-one basis with unmatched
focus on privacy and data ownership. The AI Platform-as-a-Service approach supports rapid
development and effective deployment of bespoke and transformative use cases, such as
human-centric and hyper-personalised consumer interactions, new and innovative mobility
services, intelligent banking, usage and lifestyle based insurance, predictive health tracking
and coaching, and many more.
Sentiance recently announced an extended partnership with Autoliv, a world leader in car
safety equipment, to develop the world’s best crash detection and crash reconstruction
system, utilising smartphone and smart wearable sensor data. Separately, a partnership with
one of the largest technology players worldwide was finalised in developing intelligent family
safety service offerings utilising Sentiance core IP. Other well-known and publicly named
clients of Sentiance include Uber, Careem, Absa, Samsung, Trove, Sparebank/Fremtind and
Risk Insurance.
Mid-2019 Sentiance started bespoke development of a “Consumer-to-Brand” (“C2B”)
intelligence and recommendation platform, inspired, funded and supported by MESH. Once
fully internally tested and deployed, it is anticipated that this intelligence platform will create
many new avenues globally to enable contextualised and hyper personalised consumer
service offerings delivering clearly defined benefits for consumers and brands alike.
2
Over the next 15 months Sentiance expects to complete internal edge computing
development work leading to the implementation of full “on-device processing”. This will
significantly enhance its already market leading proposition and materially further increase
client return on investment whilst fully maintaining and guaranteeing data control and
ownership by the user. Through the proposed 100% a

Asimilar Group plc



('Asimilar' or the 'Company')



Update on proposed transaction with Sentiance



Further to the announcements on 4 and 12 March 2020, Asimilar Group plc (AIM: ASLR) is working on preparing an admission document relating to the proposed subscription in and the granting of options over the equity of Sentiance N.V. ('Sentiance').



The Company notes the announcement published by Mesh Holdings plc ('Mesh') this morning that Mesh has made an offer to acquire the entire issued share capital of Sentiance.



As part of this offer, the Company has received a proposal from Mesh that Asimilar would receive compensation from Mesh in the form of new ordinary shares in Mesh in consideration for the Company novating the following to Mesh:



i) its rights to subscribe for 10,000 new Sentiance shares at a price of €750 per share ("Initial Investment");

ii) an option to purchase 32,225 existing Sentiance shares at an exercise price of €650 per share ("Option 1"); and

iii) a further option to subscribe for 10,000 new Sentiance shares at an exercise price of €750 per share ("Option 2"), all as announced by Asimilar on 4 March 2020.



The Board of Asimilar is exploring the terms of this proposal with Mesh and is pursuing appropriate due diligence to assess its merits.



In the meantime, Asimilar is continuing to work with its Nominated Adviser and other professional advisers on its admission document in relation to the proposals announced on 4 and 12 March 2020.



Further announcements will be made in due course.

The Board of Prospex Oil and Gas has announced a reorganisation of the Company's Share Capital. Shareholders as at close of business on 30 June 2020 will have their holding consolidated, receiving 1 new share in place of every 25 shares previously held. The Company will also be changing its name to Propex Energy plc at the same time.

The new consolidated Shares are expected on 1 July 2020. Please note we will credit the shares to your account upon receipt from the registrar which may not be before 8.00am on 1 July 2020.

Open Orphan plc

("Open Orphan" or the "Company")



Appointment of Joint Broker



Open Orphan plc (AIM: ORPH), the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and antivirals using human challenge study models, announces the appointment of finnCap Ltd as its joint broker with immediate effect.

close above the 200 day moving average?

chasing any rise surefire way to the poorhouse